Analysed INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) News Sources
Innovent to Present New Clinical Data of IBI363(PD-1/IL-2α-biased bispecific fusion protein) at the 2026 ASCO Annual Meeting
22-04-2026
yahoo.com
Immune Resetting: B-Cell Mediated & Beyond Summit 2026 Oral Presentation: Innovent Biologics Announces Pre-Clinical Results of IBI3055, a Tri-specific T Cell Engager Targeting Autoimmune Diseases
10-04-2026
yahoo.com
Altruist Biologics' Hangzhou Facility Secures First Commercial Manufacturing License
08-04-2026
yahoo.com
Assessing Innovent Biologics (SEHK:1801) Valuation After Strong Recent Share Price Momentum
04-04-2026
yahoo.com
Innovent's Partner Ollin Biosciences Announces Final Data from Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo) in Wet Age-Related Macular Degeneration and Diabetic Macular Edema
31-03-2026
yahoo.com
Ollin Biosciences Announces Final Data From Randomized Head-to-Head Study of OLN324 Compared to Faricimab (Vabysmo®) in Wet Age-Related Macular Degeneration and Diabetic Macular Edema
30-03-2026
yahoo.com
The Phase 3 Registration STAR Study of Efdamrofusp Alfa (IBI302) Met its Primary Endpoint, Making it the First Self-developed Extended-interval Treatment for nAMD in China
24-03-2026
yahoo.com
What is the current price of INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS)?
The current price of INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) is $11.2.
INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) since the previous trading day is $0.0892.
INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) since the previous trading day is 0.8028%.
What is the most recent average sentiment score for INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS)?
The most recent average sentiment score for INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) is 75 out of 100.
What is the most recent average sentiment for INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS)?
The most recent sentiment for INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) is .
SEC-8K** Filing Available For INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.